These analyses reveal that the expression of multiple C1q genes (i.e., C1QA, C1QB, and C1QC) associate with a better OS outcome in patients with HER2+ BC, compared with TNBC or Luminal A/B subtypes (Figure 6D and Supplemental Figures 10 and 11). Here, C1QC is linked to breast cancer.